Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Application of an intracellular assay for determination of tenofovir-diphosphate and emtricitabine-triphosphate from erythrocytes using dried blood spots
Jia‐Hua Zheng, Caitlin Rower, Kevin McAllister, et al.
Journal of Pharmaceutical and Biomedical Analysis (2016) Vol. 122, pp. 16-20
Open Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy
Peter L. Anderson, Albert Liu, José Castillo‐Mancilla, et al.
Antimicrobial Agents and Chemotherapy (2017) Vol. 62, Iss. 1
Open Access | Times Cited: 241
Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study
Beatriz Grinsztejn, Brenda Hoagland, Ronaldo I. Moreira, et al.
The Lancet HIV (2018) Vol. 5, Iss. 3, pp. e136-e145
Closed Access | Times Cited: 184
High pre‐exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project
Brenda Hoagland, Ronaldo I. Moreira, Raquel B. De Boni, et al.
Journal of the International AIDS Society (2017) Vol. 20, Iss. 1
Open Access | Times Cited: 127
Adherence Measurements in HIV: New Advancements in Pharmacologic Methods and Real-Time Monitoring
José Castillo‐Mancilla, Jessica E. Haberer
Current HIV/AIDS Reports (2018) Vol. 15, Iss. 1, pp. 49-59
Open Access | Times Cited: 127
Medication adherence, condom use and sexually transmitted infections in Australian preexposure prophylaxis users
Luxi Lal, Jennifer Audsley, Dean Murphy, et al.
AIDS (2017) Vol. 31, Iss. 12, pp. 1709-1714
Closed Access | Times Cited: 117
Approaches to Objectively Measure Antiretroviral Medication Adherence and Drive Adherence Interventions
Matthew A. Spinelli, Jessica E. Haberer, Peter R. Chai, et al.
Current HIV/AIDS Reports (2020) Vol. 17, Iss. 4, pp. 301-314
Open Access | Times Cited: 117
Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial
Linda‐Gail Bekker, Surita Roux, Elaine Sebastien, et al.
The Lancet HIV (2017) Vol. 5, Iss. 2, pp. e68-e78
Open Access | Times Cited: 108
Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis Among Adolescent and Young Men Who Have Sex With Men in the United States
Catherine A. Koss, Sybil Hosek, Peter Bacchetti, et al.
Clinical Infectious Diseases (2017) Vol. 66, Iss. 2, pp. 213-219
Open Access | Times Cited: 90
Effect of SMS reminders on PrEP adherence in young Kenyan women (MPYA study): a randomised controlled trial
Jessica E. Haberer, Elizabeth A. Bukusi, Nelly Mugo, et al.
The Lancet HIV (2021) Vol. 8, Iss. 3, pp. e130-e137
Open Access | Times Cited: 60
Safety and drug quantification of the dapivirine vaginal ring and oral pre-exposure prophylaxis in breastfeeding mother–infant pairs (MTN-043): a phase 3B, open-label, randomised trial
Lisa Noguchi, Maxensia Owor, Nyaradzo Mgodi, et al.
The Lancet HIV (2025)
Closed Access | Times Cited: 1
Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case report
Elske Hoornenborg, Maria Prins, Roel Achterbergh, et al.
The Lancet HIV (2017) Vol. 4, Iss. 11, pp. e522-e528
Closed Access | Times Cited: 82
Tenofovir Diphosphate in Dried Blood Spots Is Strongly Associated With Viral Suppression in Individuals With Human Immunodeficiency Virus Infections
José Castillo‐Mancilla, Mary Morrow, Ryan P. Coyle, et al.
Clinical Infectious Diseases (2018) Vol. 68, Iss. 8, pp. 1335-1342
Open Access | Times Cited: 76
Advancing the Science and Practice of Medication Adherence
Michael J. Stirratt, Jeffrey R. Curtis, Maria I. Danila, et al.
Journal of General Internal Medicine (2017) Vol. 33, Iss. 2, pp. 216-222
Open Access | Times Cited: 75
Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing
José Castillo‐Mancilla, Sharon M. Seifert, Kayla Campbell, et al.
Antimicrobial Agents and Chemotherapy (2016) Vol. 60, Iss. 11, pp. 6692-6697
Open Access | Times Cited: 68
Urine assay for tenofovir to monitor adherence in real time to tenofovir disoproxil fumarate/emtricitabine as pre‐exposure prophylaxis
HC Koenig, Karam Mounzer, GW Daughtridge, et al.
HIV Medicine (2017) Vol. 18, Iss. 6, pp. 412-418
Open Access | Times Cited: 63
Low PrEP adherence despite high retention among transgender women in Brazil: the PrEParadas study
Emília M. Jalil, Thiago S. Torres, Paula M. Luz, et al.
Journal of the International AIDS Society (2022) Vol. 25, Iss. 3
Open Access | Times Cited: 34
Viral and host mediators of non-suppressible HIV-1 viremia
Abbas Mohammadi, Behzad Etemad, Xin Zhang, et al.
Nature Medicine (2023) Vol. 29, Iss. 12, pp. 3212-3223
Open Access | Times Cited: 20
Type 1 Human Immunodeficiency Virus (HIV-1) Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-exposure Prophylaxis: Pooled Analysis From 72 Global Studies
Raphael J. Landovitz, Tao Li, Juan Yang, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 5, pp. 1197-1207
Open Access | Times Cited: 7
Predictive Value of Tenofovir Diphosphate in Dried Blood Spots for Future Viremia in Persons Living With HIV
Mary Morrow, Samantha MaWhinney, Ryan P. Coyle, et al.
The Journal of Infectious Diseases (2019) Vol. 220, Iss. 4, pp. 635-642
Open Access | Times Cited: 51
Tenofovir Diphosphate Concentrations in Dried Blood Spots From Pregnant and Postpartum Adolescent and Young Women Receiving Daily Observed Pre-exposure Prophylaxis in Sub-Saharan Africa
Lynda Stranix‐Chibanda, Peter L. Anderson, Deborah Kacanek, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. 7, pp. e1893-e1900
Open Access | Times Cited: 49
PrEP uptake and adherence in relation to HIV-1 incidence among Kenyan men who have sex with men
Elizabeth Wahome, Susan M. Graham, Alexander N. Thiong’o, et al.
EClinicalMedicine (2020) Vol. 26, pp. 100541-100541
Open Access | Times Cited: 47
Sex Hormone Therapy and Tenofovir Diphosphate Concentration in Dried Blood Spots: Primary Results of the Interactions Between Antiretrovirals And Transgender Hormones Study
Robert M. Grant, Marion Pellegrini, Patricia Defechereux, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. 7, pp. e2117-e2123
Open Access | Times Cited: 42
Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots Following Tenofovir Alafenamide: The TAF-DBS Study
Jenna Yager, José Castillo‐Mancilla, Mustafa E. Ibrahim, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2020) Vol. 84, Iss. 3, pp. 323-330
Open Access | Times Cited: 40
“I wish to remain HIV negative”: Pre-exposure prophylaxis adherence and persistence in transgender women and men who have sex with men in coastal Kenya
Makobu Kimani, Elise van der Elst, Oscar Chirro, et al.
PLoS ONE (2021) Vol. 16, Iss. 1, pp. e0244226-e0244226
Open Access | Times Cited: 37
Adherence challenges with daily oral pre‐exposure prophylaxis during pregnancy and the postpartum period in South African women: a cohort study
Dvora Joseph Davey, Dorothy C. Nyemba, José Castillo‐Mancilla, et al.
Journal of the International AIDS Society (2022) Vol. 25, Iss. 12
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top